Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideREGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | AMGN | REGN |
|---|
| Close | 466.01 | 927.89 |
| Market Cap | $254B | $93.4B |
| 1M | +10.56% | +22.37% |
| P/E (TTM) | 28.5 | 19.5 |
| Forward P/E | 17.1 | 13.4 |
| P/E 5-Yr Percentile | 68 | 56 |
| P/S | 6.5 | 5.4 |
| P/B | 21.3 | 2.7 |
| Dividend Yield | 3.21% | 0.45% |
| Latest Quarter Revenue | $10.1B | $5.1B |
| Revenue YoY | +9.5% | +36.3% |
| Gross Margin | 72.0% | — |
| Latest Quarter EPS | 4.37 | 18.45 |
| Avg Post-Earnings Move | ±5.2% | ±1.4% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.08% | 3.66% |
| 90-Day Net Insider Buying | −$4.1M | −$6.5M |
AMGN · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
